<DOC>
	<DOCNO>NCT00255996</DOCNO>
	<brief_summary>Evaluation linezolid pk profile burn patient</brief_summary>
	<brief_title>Evaluation Of Linezolid Pk Profile In Burns Patients</brief_title>
	<detailed_description />
	<mesh_term>Linezolid</mesh_term>
	<criteria>Subject Body Mass Index ( BMI ) &lt; 30 kg/m &amp; # 178 ; . For patient major thermal injury , weight collect burn ; Patients major thermal injury &gt; 40 % body area include 3rd degree burn full thickness burn ; Patients hospitalize least 10 day since thermal injury occur ; Contraindications use linezolid mention SmPC ( Summarized Product Characteristics ) : hypersensitivity linezolid use component , noncontrolled hypertension , phaeochromocytoma , carcinoid syndrome , hyperthyroidism , bipolar disorder , schizoaffective disorder , acute confuse state mind , pregnancy , breastfeed ; Drugs metabolise monoamine oxydase ( MAO ) evaluate potential drugtodrug interaction ; Subject treat : selective serotonin reuptake inhibitor ( Prozac &amp; # 174 ; , Effexor &amp; # 174 ; , Ixel &amp; # 174 ; &amp; # 133 ; ) , tricyclic antidepressant ( Anafranil &amp; # 174 ; , Sinequan &amp; # 174 ; , Surmontil &amp; # 174 ; , Tofranil &amp; # 174 ; ) , 5HT1 receptor agonist ( triptan ) direct indirect sympathomimetic ( include adrenergic bronchodilator , pseudoephedrine phenylpropylamine ) , vasopressor ( adrenaline noradrenaline ) , dopaminergic drug ( dopamine , dobutamine ) , phenetidine buspirone evaluate potential drugtodrug interaction ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>